Epstein Secrets

BOW, MD CHIEF. DIVISION OF SURGICAL. ONCOLOGY CO.CIIAIR. GASTROENTEROLOGY DISEASE MANAGEMENT TEAM MOUNT SINAI HEALTH SYSTEM OF NEW YORK CITY AND ERIC SCHADT, PhD Han C. AND JAMES W. CRYSTAL. PROFESSOR OF GESOMICS DIRECTOR. ICAHN INSTITUTE TOR G ENOM ICS AND MULTISCALE RIOWGY MOUNT SINAI HEALTH SYSTEM O

ESSOR OF GESOMICS DIRECTOR. ICAHN INSTITUTE TOR G ENOM ICS AND MULTISCALE RIOWGY MOUNT SINAI HEALTH SYSTEM OF KEW YORK CITY Drs. Cagan, labow, and Schadt will share their groundbreaking work in precision medicine, which is changing the way diseases arc diagnosed and treated. Dr. Schadt and his collea

an, labow, and Schadt will share their groundbreaking work in precision medicine, which is changing the way diseases arc diagnosed and treated. Dr. Schadt and his colleagues develop techniques to create innovative, data-driven predictive models of human disease. Investigators like Dr. Cagan can then u

LABOW, MD CHIEF, DIVISION OF SURGICAL ONCOLOGY CO.CHAIR. GASTROENTEROLOGY DISEASE MANAGEMENT TEAM MOUNT SINAI HEALTH SYSTEM OF NEW YORK CITY AND ERIC SCHADT, PhD JEAN C. AND JAMES W. CRYSTAL PROFESSOR OF GENOMICS DIRECTOR. ICAIIN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY MOUNT SINAI HEALTH SYSTEM O

an, Labow, and Schadt will share their groundbreaking work in precision medicine, which is changing the way diseases are diagnosed and treated. Dr. Schadt and his colleagues develop techniques to create innovative, data-driven predictive models of human disease. Investigators like Dr. Cagan can then u

ESSOR OF GENOMICS DIRECTOR. ICAIIN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY MOUNT SINAI HEALTH SYSTEM OF NEW YORK CITY Drs. Cagan, Labow, and Schadt will share their groundbreaking work in precision medicine, which is changing the way diseases are diagnosed and treated. Dr. Schadt and his collea

e Plumeri. Our President and CEO Dr. Ken Davis =ill lead a discussion with three of Mount Sinai's experts in the =ield of Personalized Therapy, Drs. Eric Schadt, Ross Cagan, and Daniel =abow, who are revolutionizing the way diseases are diagnosed and =reated. I am including a =ink below to a very compelling

ery compelling article in last month's Esquire =Ilustrating what this work can mean for our patients. The =rticle, "Patient Zero," describes how Dr. Schadt's team =ith Mount Sinai colleagues — including Dr. Cagan and Dr. Labow =96 are pioneering an innovative approach to treatment for =tephanie Lee, an I

e Plumeri. Our President and CEO Dr. Ken Davis =ill lead a discussion with three of Mount Sinai's experts in the =ield of Personalized Therapy, Drs. Eric Schadt, Ross Cagan, and Daniel =abow, who are revolutionizing the way diseases are diagnosed and =reated. I am including a =ink below to a very compelling

ery compelling article in last month's Esquire =llustrating what this work can mean for our patients. The =rticle, "Patient Zero," describes how Dr. Schadt's team =ith Mount Sinai colleagues — including Dr. Cagan and Dr. Labow =96 are pioneering an innovative approach to treatment for =tephanie Lee, an I

l lead a discussion with three of Mount Sinai's experts recently featured in Esquire and CBS Morning Show in the field of Personalized Therapy, Drs. Eric Schadt, Ross Cagan, and Daniel Labow, who are revolutionizing the way diseases are diagnosed and treated. If you will be in the area at that time, we woul

ery compelling article in last month's Esquire illustrating what this work can mean for our patients. The article, "Patient Zero," describes how Dr. Schadt's team with Mount Sinai colleagues — including Dr. Cagan and Dr. Labow — are pioneering an innovative approach to treatment for Stephanie Lee, an I

l lead a discussion with three of Mount Sinai's experts recently featured in Esquire and CBS Morning Show in the field of Personalized Therapy, Drs. Eric Schadt, Ross Cagan, and Daniel Labow, who are revolutionizing the way diseases are diagnosed and treated. If you will be in the area at that time, we woul

ery compelling article in last month's Esquire illustrating what this work can mean for our patients. The article, "Patient Zero," describes how Dr. Schadt's team with Mount Sinai colleagues — including Dr. Cagan and Dr. Labow — are pioneering an innovative approach to treatment for Stephanie Lee, an I

e Plumeri. Our President and CEO Dr. Ken Davis will lead a discussion with three of Mount Sinai's experts in the field of Personalized Therapy, Drs. Eric Schadt, Ross Cagan, and Daniel Labow, who are revolutionizing the way diseases are diagnosed and treated. If he will be in the area at that time, we would

ery compelling article in last month's Esquire illustrating what this work can mean for our patients. The article, "Patient Zero," describes how Dr. Schadt's team with Mount Sinai colleagues — including Dr. Cagan and Dr. Labow — are pioneering an innovative approach to treatment for Stephanie Lee, an I